Can Abbott’s Revenue Continue To Grow In Double-Digits?
- Monday, March 9, 2020, 7:17
- Market
- Add a comment
We don’t expect Abbott’s (NYSE: ABT) revenue to grow in double-digits in the near term. The company has seen its revenue grow at a CAGR of 12.4% from $20.4 billion in 2015 to $31.9 billion in 2019, but this growth was largely driven by the impact of St Jude Medical as well as Alere acquisitions…
About the Author
admin123 has written 23442 stories on this site.
